Compare CHRS & ALCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CHRS | ALCO |
|---|---|---|
| Founded | 2010 | 1960 |
| Country | United States | United States |
| Employees | N/A | 172 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 296.8M | 297.9M |
| IPO Year | 2014 | 1994 |
| Metric | CHRS | ALCO |
|---|---|---|
| Price | $1.59 | $40.75 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $5.51 | ★ $44.00 |
| AVG Volume (30 Days) | ★ 1.3M | 14.5K |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 0.49% |
| EPS Growth | ★ 472.00 | N/A |
| EPS | N/A | ★ 1.03 |
| Revenue | N/A | N/A |
| Revenue This Year | $73.08 | N/A |
| Revenue Next Year | $30.94 | N/A |
| P/E Ratio | ★ N/A | $39.67 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.72 | $30.89 |
| 52 Week High | $2.62 | $45.01 |
| Indicator | CHRS | ALCO |
|---|---|---|
| Relative Strength Index (RSI) | 44.10 | 46.56 |
| Support Level | $1.55 | $39.98 |
| Resistance Level | $1.80 | $42.55 |
| Average True Range (ATR) | 0.12 | 1.00 |
| MACD | -0.03 | -0.05 |
| Stochastic Oscillator | 20.93 | 33.84 |
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its portfolio includes LOQTORZI which was developed for its ability to block PD-1 interactions with its ligands, PD-L1 and PD-L2, by binding to the FG loop on the PD-1 receptor. Company believe blocking PD-1 interactions with PD-L1 and PD-L2 can help to promote the immune systems.
Alico Inc is a Florida-based agribusiness and land management company that mainly focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in the cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers the majority of the revenue as the firm's primary operating business unit.